undefined(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4139

0.0000

+0.0000

--

最高0.0000	最低0.0000	成交量0.00
今开0.0000	昨收0.0000	日振幅0.00%
总市值0.00	流通市值0.00	总股本0.00
成交额0.00	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","latestPrice":0,"timestamp":0,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatusCode":0,"change":0,"open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"adr":0,"adjPreClose":0},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2483020365","title":"再鼎医药计划发售784万股存托股份，预计融资不超2.3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483020365","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483020365?lang=zh_cn&edition=full","pubTime":"2024-11-15 08:54","pubTimestamp":1731632063,"startTime":"0","endTime":"0","summary":"财中社11月15日电再鼎医药（09688/ZLAB）发布公告，计划发售784万股美国存托股份，代表7843万股相关股份，发售价为每股25.5美元。此次发售预计在2024年11月18日交割，假设期权全部行使，将增加公司普通股约9.06%。若不行使期权，则相关股份占现有已发行普通股约8.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411153240394168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4139","BK1574","09688","BK1161","BK4548","BK4588","BK4531","BK4526","ZLAB","BK1588"],"gpt_icon":0},{"id":"2483363016","title":"再鼎医药(09688)拟发售约784.31万股美国存托股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483363016","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483363016?lang=zh_cn&edition=full","pubTime":"2024-11-15 08:40","pubTimestamp":1731631219,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药 公布，于2024年11月13日，公司就发售向SEC提交初步招股章程补充文件。于2024年11月14日，公司就发售与包销商订立包销协议，据此，公司同意以发售价向包销商发行及发售合共7,843,137股美国存托股份。每股美国存托股份代表10股普通股为相关股份。每股美国存托股份的发售价为25.50美元。公司亦授予包销商30日期权，以发售价减去包销折让和佣金，额外购买1,176,470股发售中将予发行的美国存托股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09688","BK1574","BK4139","BK4531","BK4526","BK4588","ZLAB","BK1588","BK4548","BK1161","BK4585"],"gpt_icon":0},{"id":"2483836337","title":"百济神州拟将英文名称变更为“BeOne Medicines Ltd.”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483836337","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483836337?lang=zh_cn&edition=full","pubTime":"2024-11-15 08:30","pubTimestamp":1731630600,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　百济神州（06160）发布公告，就存续的目的，董事会拟议将公司英文名称从“BeiGene， Ltd．”变更为“BeOne Medicines Ltd．”并采纳包含拟议公司英文名称变更的拟议瑞士章程。公司的中文名称将保持不变。\n　　公告称，新英文名称彰显公司对研发创新药物，以及通过携手全球各界，服务更多患者从而消除癌症的承诺。董事会相信拟议公司英文名称变更符合公司和股东的整体利益。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-15/doc-incwaxxq9763547.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-15/doc-incwaxxq9763547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","LU2328871848.SGD","BK1161","BK4504","BK4588","BK1500","BK1583","BK4505","BK4139","BK4585","BK4548","BGNE","LU0307460666.USD","LU1969619763.USD","BK4526","688235","LU0588546209.SGD","06160","BK1588","BK4535"],"gpt_icon":0},{"id":"2483509513","title":"特朗普推选小肯尼迪领导美国最高卫生机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2483509513","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483509513?lang=zh_cn&edition=full","pubTime":"2024-11-15 08:00","pubTimestamp":1731628823,"startTime":"0","endTime":"0","summary":"更新 5-特朗普推选小肯尼迪领导美国最高卫生机构第 8-9 段增加了背景；第 17-18 段增加了评论；第 19 段增加了疫苗份额的变动Stephanie Kelly. 卫生优先事项 肯尼迪是特朗普过渡团队的一员，一直在审查美国卫生机构高层职位的候选人简历 。肯尼迪因发表虚假医学声明，包括疫苗与自闭症有关而受到批评。美国疾病预防控制中心本月表示，美国幼儿的疫苗接种率已低于这一水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4S3MM003:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU0058720904.USD","BK4534","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4550","BK4501","LU1883839398.USD","MRNA","BK4533","BK4548","IE00B19Z3B42.SGD","BK4585","LU0122379950.USD","SG9999011175.SGD","LU0306806265.USD","PFE","LU1066051498.USD","SGXZ57979304.SGD","BK4581","BK4007","BK4139","LU0170899867.USD","LU0234572021.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999001176.USD","SG9999013999.USD","IE00BLSP4239.USD","BK4568","LU0225284248.USD","LU0225771236.USD","LU0868494617.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0456855351.SGD","LU0306807586.USD","IE00BBT3K403.USD","LU1023059063.AUD","BK4551","LU1894683264.USD","IE0002270589.USD","SG9999003800.SGD","LU0321505439.SGD","BK4592","SG9999001176.SGD","BK4532","LU1894683348.USD","SG9999002224.SGD","LU0321505868.SGD"],"gpt_icon":1},{"id":"2483358769","title":"Halozyme 向药物开发商 Evotec 提出 20 亿欧元收购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358769","media":"路透中文","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483358769?lang=zh_cn&edition=full","pubTime":"2024-11-15 05:40","pubTimestamp":1731620400,"startTime":"0","endTime":"0","summary":"更新版 1-Halozyme 向药物开发商 Evotec 提出 20 亿欧元收购要约更改来源，在第2段增加交易细节，在第3段增加股份变动，在第6段引用首席执行官的话。Halozyme公司打算以每股11欧元的价格收购Evotec公司的全部股份，这比Evotec公司的最后收盘价溢价27.5%。由于临床研究机构业务市场环境疲软导致收入持续下滑，Evotec 公司的股价今年下跌了约 60%。Halozyme 公司收购 Evotec 公司的计划是彭博新闻社周四早些时候首次报道的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4S3ML1Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2483358940","title":"Moderna(MRNA.O)盘后下跌1%，此前特朗普表示将提名“疫苗怀疑论者”小罗伯特·肯尼迪担任美国卫生与公众服务部部长。","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358940","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483358940?lang=zh_cn&edition=full","pubTime":"2024-11-15 05:34","pubTimestamp":1731620079,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["MRNA","BK4585","BK4551","BK4532","BK4501","BK4139","BK4588","BK4548","BK4568","BK4533","159646","BK4534"],"gpt_icon":0},{"id":"2483375813","title":"据彭博新闻社报道，Halozyme 正在权衡收购制药商 Evotec","url":"https://stock-news.laohu8.com/highlight/detail?id=2483375813","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483375813?lang=zh_cn&edition=full","pubTime":"2024-11-15 05:04","pubTimestamp":1731618255,"startTime":"0","endTime":"0","summary":"路透11月14日 - 据彭博新闻社周四报道，德国制药商Evotec公司EVTG.DE正吸引美国Halozyme Therapeutics公司HALO.O的收购兴趣。报道还援引熟悉内情的人士的话说，Halozyme公司最近表示有意以每股约11欧元的价格收购Evotec公司。据报道，本周早些时候，私募股权公司Triton在确认持有Evotec近10%的股份后，也在 ，探讨收购Evotec的可能性。由于临床研究机构业务市场环境疲软导致收入持续下滑，Evotec 公司的股价今年下跌了约 60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4S3ML1XA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HALO","LU0053671581.USD"],"gpt_icon":0},{"id":"2483332130","title":"Invivyd 公司报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332130","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332130?lang=zh_cn&edition=full","pubTime":"2024-11-15 05:00","pubTimestamp":1731618000,"startTime":"0","endTime":"0","summary":"Invivyd 公司报告本季度业绩 - 收益摘要Invivyd Inc IVVD.OQ报告本季度调整后每股亏损51美分，低于去年同期的每股收益-36美分。四位分析师对该季度的平均预期是每股亏损 34 美分。Invivyd Inc公布的本季度每股收益为亏损51美分。该公司当季亏损 6,074 万美元。Invivyd Inc本季度股价下跌了12.7%，今年迄今为止亏损了77.4%。华尔街对 Invivyd 公司 12 个月目标价的中位数为 9.00 本摘要由 LSEG 11 月 14 日 08:59 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML1WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2483754332","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅上涨5.14%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483754332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483754332?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:59","pubTimestamp":1731617973,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时59分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.14%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.01%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045933abc2198d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045933abc2198d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2483332133","title":"Sensei Biotherapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332133","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332133?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:59","pubTimestamp":1731617960,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Sensei Biotherapeutics Inc SNSE.OQ报告了截至9月30日的季度调整后每股亏损29美分，低于去年同期的每股收益-28美分。四位分析师对该季度的平均预期是每股亏损 31 美分。Sensei Biotherapeutics Inc 报告的季度每股收益为亏损 29 美分。该公司当季亏损 725 万美元。Sensei Biotherapeutics Inc 的股价本季度下跌了 11.1%，今年迄今为止下跌了 23.2%。华尔街对 Sensei Biotherapeutics Inc 的 12 个月目标价中位数为 4.00 本摘要由 LSEG 11 月 14 日 08:58 p.m. UTC 数据机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4S3ML1WG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNSE"],"gpt_icon":0},{"id":"2483533208","title":"Precision Biosciences, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483533208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483533208?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:56","pubTimestamp":1731617795,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时56分，Precision Biosciences, Inc.股票出现异动，股价急速跳水5.07%。Precision Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.04%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为4971.41%、3498.78%、404.66%，振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为249.67%、218.18%、188.46%。Precision Biosciences, Inc.公司简介：Precision BioSciences Inc 是一家基因组编辑公司，致力于通过其基因组编辑平台ARCUS改善生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504563598e42bb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504563598e42bb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DTIL"],"gpt_icon":0},{"id":"2483532332","title":"PDS 生物技术公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483532332","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483532332?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:55","pubTimestamp":1731617737,"startTime":"0","endTime":"0","summary":"PDS 生物技术公司报告截至 9 月 30 日的季度业绩 - 收益摘要PDS Biotechnology Corp PDSB.OQ报告，截至9月30日的季度调整后每股亏损29美分，高于去年同期的每股-35美分。PDS 生物技术公司公布的季度每股收益为亏损 29 美分。公司报告的季度亏损额为 1,073 万美元。PDS 生物技术公司本季度股价下跌了 27.9%，今年迄今为止下跌了 44.6%。生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 PDS 生物技术公司 12 个月目标价的中位数为 9.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4S3ML1VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PDSB"],"gpt_icon":0},{"id":"2483379913","title":"Vericel Corporation盘中异动 快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483379913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483379913?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:55","pubTimestamp":1731617734,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时55分，Vericel Corporation股票出现异动，股价大幅下跌5.08%。Vericel Corporation股票所在的生物技术行业中，整体跌幅为2.06%。Vericel Corporation公司简介：Vericel Corp是一家全面一体化的商业化阶段的生物制药公司，专注于运动医学和严重烧伤护理市场的各种疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045534971a6a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045534971a6a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2483332337","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332337?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:54","pubTimestamp":1731617693,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时54分，Kymera Therapeutics, Inc.股票出现波动，股价急速下跌5.22%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.03%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504545398e42bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504545398e42bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2483325313","title":"BUZZ-Windtree 因首席执行官退休而下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2483325313","media":"路透中文","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483325313?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:54","pubTimestamp":1731617693,"startTime":"0","endTime":"0","summary":"BUZZ-Windtree 因首席执行官退休而下滑11月14日 -  ** 生物技术公司Windtree Therapeutics WINT.O股价下跌8.30%，收于约0.49美元 ** 首席执行官克雷格-弗雷泽将于12月1日退休 ** 弗雷泽将继续担任董事会主席 ** 现任董事杰德-拉特金被任命为首席执行官 ** 包括盘中涨幅在内，该股今年累计下跌了 96.1%(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML1UV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00950","WINT","BK4139"],"gpt_icon":0},{"id":"2483133279","title":"Arcutis Biotherapeutics, Inc.盘中异动 股价大跌5.06%报9.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483133279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483133279?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:54","pubTimestamp":1731617691,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时54分，Arcutis Biotherapeutics, Inc.股票出现异动，股价快速跳水5.06%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.03%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为4959.88%、3495.22%、403.71%，振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为249.67%、218.18%、188.46%。Arcutis Biotherapeutics, Inc.公司简介：Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504545198e42bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504545198e42bb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2483723332","title":"Cellectar Biosciences, Inc.盘中异动 快速跳水5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483723332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483723332?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:53","pubTimestamp":1731617628,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时53分，Cellectar Biosciences, Inc.股票出现波动，股价快速下挫5.21%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为4952.18%、3493.33%、403.47%，振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为249.67%、218.18%、188.46%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045348a2388f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045348a2388f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2483433270","title":"Cyclo Therapeutics, Inc.盘中异动 临近收盘快速下跌6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483433270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483433270?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:52","pubTimestamp":1731617556,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时52分，Cyclo Therapeutics, Inc.股票出现异动，股价急速下挫6.94%。Cyclo Therapeutics, Inc.股票所在的制药行业中，整体跌幅为2.04%。Cyclo Therapeutics, Inc.公司简介：Cyclo Therapeutics Inc 是一家临床阶段的生物技术公司。收入主要来自向制药和营养行业销售环糊精及相关产品，其中Trappsol HPB 和Trappsol Fine Chemical 是主要贡献因素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045236abc216e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045236abc216e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYTH","BK4139","LENZ"],"gpt_icon":0},{"id":"2483307303","title":"Inhibrx Biosciences, Inc.盘中异动 临近收盘急速下挫5.24%报14.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483307303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483307303?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:50","pubTimestamp":1731617413,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时50分，Inhibrx Biosciences, Inc.股票出现波动，股价快速下跌5.24%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.09%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045013971a6a2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045013971a6a2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2483332798","title":"Adma Biologics Inc盘中异动 临近收盘股价大跌5.12%报20.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332798?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:44","pubTimestamp":1731617097,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时44分，Adma Biologics Inc股票出现异动，股价急速下跌5.12%。截至发稿，该股报20.37美元/股，成交量215.088万股，换手率0.91%，振幅4.35%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为1.93%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044457971a6a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044457971a6a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0798},{"period":"6month","weight":0.1279},{"period":"1year","weight":0.3308},{"period":"ytd","weight":0.2564}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"undefined(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供undefined(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":",BK4139,股票,股票老虎,股票老虎国际,行情,股票行情,股价,股市,股票价格,股票交易,股票购买,股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"undefined(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供undefined(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}